Nishanth Arun, Nathan Gaw, Praveer Singh, Ken Chang, Mehak Aggarwal, Bryan Chen, Katharina Hoebel, Sharut Gupta, Jay Patel, Mishka Gidwani, Julius Adebayo, Matthew D. Li, Jayashree Kalpathy-Cramer
4 min
As deep learning models become standard in radiology, clinicians require methods to interpret model decisions. Saliency maps—visual heatmaps highlighting image regions that influence a model's prediction—are frequently used for this purpose. This study investigates whether these maps are actually trustworthy for localizing clinical abnormalities, assessing their utility, sensitivity to model weights, repeatability, and reproducibility.
The researchers evaluated eight common saliency methods (including Gradient, Smoothgrad, Integrated Gradients, and XRAI) using two large, publicly available chest radiograph datasets: the SIIM-ACR Pneumothorax Segmentation dataset and the RSNA Pneumonia Detection Challenge dataset. They compared these methods against two baselines: a low-performance baseline (a simple average of all ground-truth masks) and a high-performance baseline (dedicated segmentation or detection networks like U-Net and RetinaNet). The study measured localization utility via the area under the precision-recall curve (AUPRC) and assessed robustness through model weight randomization, intra-architecture repeatability, and inter-architecture reproducibility.
The results indicate that saliency maps are poor substitutes for dedicated localization models. All eight tested saliency methods failed at least one of the four trustworthiness criteria. In terms of utility, most saliency maps performed no better—and often worse—than a simple average mask of all training data. Dedicated models like U-Net and RetinaNet significantly outperformed all saliency methods in localizing abnormalities. Furthermore, several saliency methods failed the model randomization test, meaning they produced similar maps even when the underlying model weights were randomized, suggesting the maps were not actually reflecting the model's learned features.
Saliency maps are often used to justify clinical trust in AI, but this study suggests they may provide a false sense of security. Because these maps fail to reliably localize abnormalities and often lack sensitivity to the model's actual training, they are not suitable for high-stakes clinical decision-making. The authors strongly recommend that if the goal is to localize an abnormality, researchers should use dedicated segmentation or detection architectures rather than relying on post-hoc interpretability methods.
Alex: It's a bit like asking someone who can only tell you whether a room is messy to then draw you a map of where all the clutter is. They might sketch something, but it wouldn't be reliable.
Sam: That's a fair way to put it. And the consequences in a medical setting are real. If a clinician sees a heat map lighting up a particular region of a scan, they may adjust their judgment based on that—even if the map is essentially decorative. The study is a reminder that in medicine, the method of explanation matters as much as the prediction itself.
Alex: So we're potentially relying on tools that look transparent but aren't actually showing us what's happening under the hood.
Sam: That's the gap the study identifies—between how widely these interpretability tools are used and how well they actually hold up under scrutiny. The authors aren't saying AI has no place in medical imaging. They're saying that before we trust an AI's explanation in a high-stakes setting, we need to test that explanation just as rigorously as we test the diagnosis itself.
Alex: A useful reminder that understanding *why* an AI made a decision is a separate—and harder—problem than getting the decision right in the first place. Thanks for listening to ResearchPod.